Search

Author/Creator Coppell, Alex

1. Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Issue 6 (14th June 2021)

Authors:
Bame, Eris; Tang, Hao; Burns, Jeremy C; Arefayene, Million; Michelsen, Klaus; Ma, Bin; Marx, Isaac; Prince, Robin; Roach, Allie M; Poreci, Urjana; Donaldson, Douglas; Cullen, Patrick; Casey, Fergal; Zhu, Jing; Carlile, Thomas M; Sangurdekar, Dipen; Zhang, Baohong; Trapa, Patrick; Santoro, Joseph;...
Journal:
Clinical & translational immunology
Issue:
Volume 10:Issue 6(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial. (August 2015)

Authors:
Batista, Jose E.; Kölbl, Heinz; Herschorn, Sender; Rechberger, Tomasz; Cambronero, Javier; Halaska, Michael; Coppell, Alex; Kaper, Mathilde; Huang, Moses; Siddiqui, Emad
Journal:
Therapeutic advances in urology
Issue:
Volume 7:Number 4(2015:Aug.)
Page Start:
167
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗